Biomea Fusion Debt To Equity vs. Market Capitalization
| BMEA Stock | USD 6.93 0.49 7.61% |
Debt To Equity | First Reported 2010-12-31 | Previous Quarter 0.01457128 | Current Value 0.0153 | Quarterly Volatility 0.00311168 |
For Biomea Fusion profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biomea Fusion to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biomea Fusion utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biomea Fusion's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biomea Fusion over time as well as its relative position and ranking within its peers.
Biomea |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.01) | Return On Assets (0.56) | Return On Equity (1.05) |
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomea Fusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biomea Fusion Market Capitalization vs. Debt To Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Biomea Fusion's current stock value. Our valuation model uses many indicators to compare Biomea Fusion value to that of its competitors to determine the firm's financial worth. Biomea Fusion is rated third in debt to equity category among its peers. It is rated fourth in market capitalization category among its peers creating about 13,728,072,471 of Market Capitalization per Debt To Equity. At present, Biomea Fusion's Debt To Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biomea Fusion's earnings, one of the primary drivers of an investment's value.Biomea Market Capitalization vs. Debt To Equity
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Biomea Fusion |
| = | 0.02 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Biomea Fusion |
| = | 233.38 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Biomea Market Capitalization vs Competition
Biomea Fusion is rated fourth in market capitalization category among its peers. Market capitalization of Health Care industry is currently estimated at about 4.5 Billion. Biomea Fusion holds roughly 233.38 Million in market capitalization claiming about 5% of equities under Health Care industry.
Biomea Fusion Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Biomea Fusion, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biomea Fusion will eventually generate negative long term returns. The profitability progress is the general direction of Biomea Fusion's change in net profit over the period of time. It can combine multiple indicators of Biomea Fusion, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.1 K | -1.2 K | |
| Net Interest Income | 8.9 M | 9.3 M | |
| Interest Income | 8.9 M | 9.3 M | |
| Operating Income | -126.1 M | -119.8 M | |
| Net Loss | -117.3 M | -111.4 M | |
| Income Before Tax | -117.3 M | -111.4 M | |
| Total Other Income Expense Net | 8.9 M | 9.3 M | |
| Net Loss | -73.6 M | -70 M | |
| Net Loss | -117.3 M | -111.4 M | |
| Income Tax Expense | -1.6 M | -1.5 M | |
| Non Operating Income Net Other | 1.6 M | 1.4 M | |
| Change To Netincome | 11.9 M | 12.5 M | |
| Net Loss | (3.44) | (3.61) | |
| Income Quality | 0.82 | 0.96 | |
| Net Income Per E B T | 1.12 | 1.08 |
Biomea Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Biomea Fusion. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biomea Fusion position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biomea Fusion's important profitability drivers and their relationship over time.
Use Biomea Fusion in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomea Fusion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will appreciate offsetting losses from the drop in the long position's value.Biomea Fusion Pair Trading
Biomea Fusion Pair Trading Analysis
The ability to find closely correlated positions to Biomea Fusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomea Fusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomea Fusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomea Fusion to buy it.
The correlation of Biomea Fusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomea Fusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomea Fusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomea Fusion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Biomea Fusion position
In addition to having Biomea Fusion in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Funds Thematic Idea Now
Healthcare Funds
Funds or Etfs investing in medical and healthcare goods or services as well as hospital management or maintenance organizations. The Healthcare Funds theme has 35 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
To fully project Biomea Fusion's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biomea Fusion at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biomea Fusion's income statement, its balance sheet, and the statement of cash flows.